Evaluation of the Digestive and Metabolic Utilisation of Dietary Protein in Patients With Chronic Pancreatitis

The objective is to evaluate the dietary nitrogen assimilation and metabolic utilisation capability of patients with chronic pancreatitis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Pancreatitis Chronic Disease Digestive System Diseases Disease Attributes Exocrine Pancreatic Insufficiency Pancreatic Diseases Pancreatitis Pancreatitis, Chronic Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

subjects with chronic pancreatitis and taking enzyme replacement therapy

Exclusion criteria

patients with hepatic impairment
patients allergic to dairy proteins
urinary incontinence affecting the measurement of nitrogen metabolism
digestive disorder affecting the absorption of nutrients

Treatment and study plan

CREON

Drug

Primary outcomes

To measure digestive and metabolic assimilation of dietary proteins in patients with chronic pancreatitis

Secondary outcomes

To determine the efficacy of enzyme therapy

Sponsors and collaborators

Lead sponsor

Hospital Avicenne

Other

Collaborators

Solvay Pharmaceuticals

Registry information

Important dates

Study start: 2004
Primary completion: 2005
Study completion: 2005
First posted: Aug 12, 2009
Registry last updated: Aug 12, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed